FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA: PDUFA 7 CMC Commitments Complete

FDA publishes a strategy document on facilitating chemistry, manufacturing, and controls readiness for products in accelerated development, completing...

latest-news-card-1
Human Drugs

Efforts Needed to Improve Health Outcomes, Califf Says

Former FDA commissioner Rob Califf tells a cardiology technology convention that the U.S. needs to make significant changes to improve population heal...

latest-news-card-1
Human Drugs

HELP Committee Advances Biosimilar Bill

The Senate HELP Committee advances legislation sponsored by Sen. Rand Paul that he says will speed approval of biosimilar drugs by eliminating require...

latest-news-card-1
Human Drugs

FDA Cites SGS France Life Sciences Over Bioanalytical Method Validation

A just-posted Form FDA 483 cites SGS France Life Sciences following an 8/2025 inspection, identifying multiple deficiencies involving bioanalytical me...

latest-news-card-1
Biologics

J&J Reports Positive Data From Multiple Myeloma Study

Johnson & Johnson reports promising topline results from the three-arm investigational Phase 3 MonumenTAL-6 study evaluating Tecvayli (teclistamab-cqy...

latest-news-card-1
Human Drugs

Lillys Retatrutide Hits Endpoint in 2 Trials

Lilly says its triple hormone receptor agonist retatrutide met the primary weight loss endpoint in two Phase 3 trials.

latest-news-card-1
Human Drugs

FDA Should Ban DTC Drug Ads: Public Citizen

Advocacy group Public Citizen files a petition urging FDA to ban prescription drug direct-to-consumer advertising.

latest-news-card-1
Human Drugs

FDA Accepts Revolution Medicines' NDA for Pancreatic Cancer Therapy

FDA accepts for review Revolution Medicines' NDA for daraxonrasib, an investigational oral RAS-targeted therapy for patients with previously treated m...

latest-news-card-1

2026 Warning Letter Trends Analyzed by Attorney

Attorney Megan Robertsons analysis of 2026 FDA Warning Letters shows that CDER has been the most active Center, going after telehealth companies selli...

latest-news-card-1
Human Drugs

4 Observations in Behring German Facility Inspection

FDA releases the form FDA-483 issued following a 2026 inspection at the CSL Behring biological drug manufacturing facility in Marburg, Hessia, Germany...